Effective of Early Treatment of Insomnia on the Adherence of CPAP

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-65
SponsorCentre Hospitalier Universitaire Vaudois

About this trial

This study includes patients suffering from both sleep apnea and insomnia. All participants receive treatment with CPAP. Half of the participants additionally receive a digital program to treat insomnia, initiated at the same time as CPAP. The other half follows usual care and will be able to access the program after 6 months. The aim is to determine whether treating insomnia earlier improves CPAP use and overall health.

Eligibility criteria

Qualifiers

45-65 years of age

Diagnosis of OSAS by respiratory polygraphy or polysomnography with an apnea-hypopnea index (AHI) ≥20 when scored by PSG or ≥15 when scored by PG30 with a prescription for CPAP therapy

Diagnosis of chronic insomnia according to the International Classification of Sleep Disorders (ICSD 3-TR).31

Ability to communicate in French

Disqualifiers

Current treatment for OSAS

Current or past treatment for chronic insomnia (CBT-I)

Severe restless legs syndrome

REM sleep behaviour disorder

Trial design

Treatments tested in this trial

  • digital CBT-I
  • CPAP

Treatment groups

120 Participants
are divided into 2 treatment groups

Locations

This trial has no locations